Nebenwirkungen · Ozurdex
OZURDEX 700 micrograms intravitreal implant in applicator · Abschnitt 4.8 · PDF-Seite 7
HOS-122532 · Präparat HOS-095531
System organ class Frequency Adverse reaction Nervous system disorders Common Headache Uncommon Migraine Eye disorders Very common Intraocular pressure increased**, cataract**, conjunctival haemorrhage* Common Ocular hypertension, cataract subcapsular, vitreous haemorrhage**, visual acuity reduced*, visual impairment/disturbance, vitreous detachment*, vitreous floaters*, vitreous opacities*, blepharitis, eye pain*, photopsia*, conjunctival oedema* conjunctival hyperaemia* Uncommon Necrotizing retinitis, endophthalmitis*, glaucoma, retinal detachment*, retinal tear*, hypotony of the eye*, anterior chamber inflammation*, anterior chamber cells/flares*, abnormal sensation in eye*, eyelids pruritus, scleral hyperaemia* General disorders and Uncommon Device dislocation* (migration of implant) with or administration site without corneal oedema/corneal decompensation conditions (see also section 4.4), complication of device insertion resulting in ocular tissue injury* (implant misplacement)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-29T16:00:00Z · SHA-256 53363d650dca503ce72c050813175e5baa834767d0b4c57e771b47a209bcad35 · Passage f4e43e84fc178217059d75b310a36c63fdcbbf7d6f9412a6c26fc8dbfe199809 · Zeichen 1164–3225 im Abschnitt